The global veterinary molecular diagnostics market size reached US$ 690.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,391.9 Million by 2032, exhibiting a growth rate (CAGR) of 7.9% during 2024-2032. More Info:- https://www.imarcgroup.com/veterinary-molecular-diagnostics-market

1. Global Veterinary
Molecular Diagnostics
Market Research and
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Veterinary Molecular
Diagnostics Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2024-2032," the global veterinary molecular
diagnostics market size reached US$ 690.8 Million in 2023.
Veterinary molecular diagnostics comprise advanced laboratory methods to
detect, identify, and genotype various viral, bacterial, and vector-borne
pathogens among animals. Some commonly utilized molecular-based
techniques include polymerase chain reaction (PCR), in situ hybridization
(ISH), nucleic acid sequence-based amplification (NASBA), and proteomics.
They aid clinicians in examining the ribonucleic acid (RNA), deoxyribonucleic
acid (DNA), or other proteins in animals to diagnose diseases or the
predisposition stage. In recent years, veterinary molecular diagnostics have
gained immense traction across research laboratories and veterinary health
centers since they facilitate rapid and highly accurate detection of nucleic
acids and diagnosis of infectious diseases.
Request for a PDF sample of this report:
https://www.imarcgroup.com/veterinary -molecular-diagnostics-
market/requestsample

4. Report Description
Global Veterinary Molecular Diagnostics Market Trends:
The surging incidences of zoonotic diseases and the rising animal husbandry activities represent the primary
factors driving the market growth. Besides this, the expanding livestock population due to the escalating demand
for animal-derived products is another major growth-inducing factor. In addition, there has been widespread
adoption of veterinary molecular diagnostics due to growing food safety concerns. Along with this, the increasing
pet ownership rates and the emerging pet humanization trend have augmented the product demand owing to the
rising awareness about animal health and wellbeing among pet parents. Furthermore, the recent advancements in
proteomics and nanotechnology have led to the development of innovative, fully automated, and high throughput
systems. In line with this, the surging demand for customized reagents and kits has catalyzed market growth.
Moreover, the sudden outbreak of coronavirus disease (COVID-19) has accelerated the adoption of PCR testing to
examine the effect of the infection in animals. Other factors, including the launch of advanced genotyping
techniques, favorable government initiatives, rising adoption of pet insurance policies, increasing pet healthcare
expenditure, development in the animal healthcare sector, and product innovations, are also providing a positive
thrust to the market growth.
Looking forward, IMARC Group expects the market value to reach US$ 1,391.9 Million by 2032, expanding at
a CAGR of 7.9% during the forecast period (2024-2032).
View Report TOC, Figures and Tables: https://www.imarcgroup.com/veterinary-molecular-diagnostics-
market

5. Report
Segmentation
Breakup by Product:
• Kits and Reagents
• Instruments
• Software and Services
Breakup by Technology:
• Real Time PCR
• Microarray
• DNA Sequencing
Breakup by Animal Type:
• Companion Animal
• Livestock Animal
Breakup by Disease Type:
• Vector-borne Diseases
• Respiratory Pathogens

6. Report
Segmentation
• Diarrhea Pathogens
• Others
Breakup by End User:
• Veterinary Hospitals
• Clinical Laboratories
• Research Institutes
Breakup by Region:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Biochek B.V.
• bioMérieux SA
• HealthGene Corporation
• Heska Corporation
• IDEXX Laboratories Inc.
• INDICAL BIOSCIENCE GmbH
• Ingenetix GmbH
• NEOGEN Corporation
• Qiagen N.V
• Thermo Fisher Scientific Inc.
• Veterinary Molecular Diagnostics Inc.
• Zoetis Inc.

8. Key Questions
Answered in
the Report
What was the size of the global veterinary molecular
diagnostics market in 2023?
What is the expected growth rate of the global veterinary
molecular diagnostics market during 2024-2032?
What are the key factors driving the global veterinary
molecular diagnostics market?
What has been the impact of COVID-19 on the global
veterinary molecular diagnostics market?
What is the breakup of the global veterinary molecular
diagnostics market based on the product?
What is the breakup of the global veterinary molecular
diagnostics market based on the technology?

9. Key Questions
Answered in
the Report
What is the breakup of the global veterinary molecular
diagnostics market based on the animal type?
What is the breakup of the global veterinary molecular
diagnostics market based on the disease type?
What are the key regions in the global veterinary molecular
diagnostics market?
Who are the key players/companies in the global veterinary
molecular diagnostics market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Veterinary Molecular Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Kits and Reagents
6.1.1 Market Trends
6.1.2 Mark et Forecast
6.2 Instruments
6.2.1 Mark et Trends
6.2.2 Mark et Forecast
6.3 Software and Services
6.3.1 Mark et Trends
6.3.2 Mark et Forecast
7 Market Breakup by Technology

11. Table of
Contents
7.1 Real T ime PCR
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Microarray
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 DNA Seq uencing
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
8 Market Breakup by Animal Type
8.1 Companion Animal
8.1.1 Mark et Trends
8.1.2 Mark et Forecast
8.2 Livestock Animal
8.2.1 Mark et Trends
8.2.2 Mark et Forecast
9 Market Breakup by Disease Type
9.1 Vector-borne Diseases
9.1.1 Mark et Trends
9.1.2 Mark et Forecast
9.2 Respiratory Pathogens
9.2.1 Mark et Trends
9.2.2 Mark et Forecast
9.3 Diarrhea Pathogens
9.3.1 Market Trends
9.3.2 Mark et Forecast
9.4 Others
9.4.1 Mark et Trends
9.4.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/veterinary -molecular-
diagnostics-market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com